NYSE · NGVT
Basic Materials · Chemicals - Specialty
$74.19
Up+$3.16 (+4.45%)
Updated Oct 28, 2026, 7:09 AM
SID Score
5.5/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · NGVT
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 27, 2026
NGVT closed at $74.19 after 21 trading sessions, up 4.40% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 27, 2026 | $71.39 | $74.31 | $71.07 | $74.19 | 459.72K |
| Oct 26, 2026 | $70.20 | $72.1301 | $70.035 | $71.03 | 372.77K |
| Oct 23, 2026 | $68.86 | $70.035 | $68.43 | $69.64 | 233.49K |
| Oct 22, 2026 | $70.27 | $71.1912 | $69.335 | $69.84 | 247.54K |
| Oct 21, 2026 | $70.76 | $71.69 | $69.90 | $70.69 | 268.28K |
| Oct 20, 2026 | $70.24 | $72.23 | $70.185 | $70.60 | 264.5K |
| Oct 19, 2026 | $70.01 | $71.02 | $69.5985 | $70.31 | 208.77K |
| Oct 16, 2026 | $70.60 | $71.87 | $69.71 | $69.82 | 210.98K |
| Oct 15, 2026 | $70.53 | $71.23 | $69.78 | $70.54 | 174.86K |
| Oct 14, 2026 | $69.32 | $71.035 | $69.05 | $70.14 | 291.48K |
| Oct 13, 2026 | $69.27 | $70.765 | $68.74 | $70.08 | 318.2K |
| Oct 12, 2026 | $69.20 | $69.87 | $68.90 | $69.07 | 280.48K |
| Oct 9, 2026 | $71.83 | $72.23 | $69.52 | $69.76 | 224.01K |
| Oct 8, 2026 | $70.44 | $72.17 | $70.44 | $71.41 | 245.27K |
| Oct 7, 2026 | $71.68 | $72.33 | $70.72 | $70.92 | 330.93K |
| Oct 6, 2026 | $73.80 | $73.80 | $72.20 | $72.80 | 237.74K |
| Oct 5, 2026 | $71.81 | $73.40 | $71.26 | $73.14 | 297.84K |
| Oct 2, 2026 | $72.28 | $73.65 | $72.0354 | $72.41 | 178.6K |
| Oct 1, 2026 | $69.83 | $71.855 | $68.60 | $71.09 | 274.33K |
| Sep 30, 2026 | $71.42 | $71.42 | $69.81 | $70.75 | 406.18K |
| Sep 29, 2026 | $73.18 | $73.18 | $70.82 | $71.06 | 260.2K |
The latest Smart Investors Daily articles mentioning NGVT.
Company
Market Activity
Research & News
NGVT research
Company profile and research snapshot.
Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The Company generates the majority of its revenue from North America.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Feb 27, 2026 | Wells Fargo | Equal-Weight | — |
| Jan 29, 2026 | Wells Fargo | Equal-Weight | — |
| Dec 19, 2025 | Wells Fargo | Equal-Weight | — |
| Dec 10, 2025 | BMO Capital | Outperform | — |
| Nov 12, 2025 | Wells Fargo | Equal-Weight | — |
No generated briefing is available yet.
Yahoo · Oct 26, 2026
The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.
Yahoo · Oct 15, 2026
Ingevity's Q2 adjusted EBITDA rose to $115 million, driven by favorable pricing, product mix and volumes, prompting higher 2026 earnings guidance.
Yahoo · Oct 7, 2026
NGVT's portfolio reshaping, acquisitions and strong cash flow support growth, while APT weakness and macro risks cloud the outlook.
Yahoo · Oct 7, 2026
NORTH CHARLESTON, S.C., October 07, 2026--Ingevity announced today that it will release its third quarter 2026 earnings after the stock market close on Wednesday, November 4, 2026.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning NGVT.
